Colon Cancer Clinical Trial

Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps

Summary

This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.

View Full Description

Full Description

PRIMARY OBJECTIVE:

I. To increase completion of surveillance colonoscopy within 3.5 years of high risk neoplasia (HRN) diagnosis.

OUTLINE:

AIM 1: Participants complete an interview over 20-30 minutes.

AIM 2: Primary care clinics are randomized to 1 of 2 arms.

ARM I: Clinics have the automatic addition of HRN to the medical problem list and indication of surveillance interval is added to the health maintenance portion of the electronic health records. Clinics also call patients to schedule their colonoscopy. Providers receive reminders and pending orders for the colonoscopy in the electronic health record. Patients receive a reminder 6 months in advance via their patient portal and mail to schedule a colonoscopy, and also receive a phone call from the patient communication center.

ARM II: Patients receive care according to the clinics' usual care practices.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

AIM 1 PATIENTS: Patients between age 45 and 75 with a HRN diagnosis in the past 5 years
AIM 1 PATIENTS: 12 patients who did and 12 patients who did not have surveillance colonoscopy
AIM 1 PROVIDERS: Primary care providers (PCPs) and gastroenterologists (GIs)
AIM 1 ADMINISTRATORS: Administrators who are involved in care processes related to CRC screening, HRN surveillance, and/or colonoscopy scheduling
AIM 2: Patients age 45 to 75 diagnosed with a HRN during the pre-specified two-year HRN diagnosis period

Exclusion Criteria:

AIM 2: Individuals with a personal history of colorectal carcinoma (CRC), inflammatory bowel disease (Crohn's, ulcerative colitis), or polyposis syndrome
AIM 2: HRN cases not confirmed by chart review (human-in-the-loop)

Study is for people with:

Colon Cancer

Estimated Enrollment:

1680

Study ID:

NCT06376565

Recruitment Status:

Not yet recruiting

Sponsor:

Jonsson Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UCLA / Jonsson Comprehensive Cancer Center
Los Angeles California, 90095, United States More Info
Folasade P. May
Contact
617-620-7806
[email protected]
Folasade P. May
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

1680

Study ID:

NCT06376565

Recruitment Status:

Not yet recruiting

Sponsor:


Jonsson Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.